Literature DB >> 6507365

Phase II study of VM 26 in extensively pretreated breast cancer.

U Tirelli, G Franchin, D Crivellari, A Veronesi, E Galligioni, M G Trovó, R Talamini, S Tumolo, E Grigoletto.   

Abstract

A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6507365     DOI: 10.1097/00000421-198410000-00011

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  2 in total

1.  Phase II study of teniposide in advanced breast cancer.

Authors:  J Boas; D Rasmussen; O P Hansen; S A Engelholm; P Dombernowsky
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Teniposide is not effective in chronic lymphocytic leukemia.

Authors:  V Zagonel; U Tirelli; A Veronesi; E Galligioni; S Tumolo; M Roncadin; A Carbone; E Grigoletto
Journal:  Blut       Date:  1986-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.